Spontaneous-Breathing Trials with ...
Document type :
Article dans une revue scientifique
DOI :
Permalink :
Title :
Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece
Author(s) :
Thille, Arnaud W. [Auteur]
Gacouin, Arnaud [Auteur]
Coudroy, Rémi [Auteur]
Ehrmann, Stephan [Auteur]
Quenot, Jean-Pierre [Auteur]
Nay, Mai-Anh [Auteur]
Guitton, Christophe [Auteur]
Contou, Damien [Auteur]
Labro, Guylaine [Auteur]
Reignier, Jean [Auteur]
Pradel, Gael [Auteur]
Beduneau, Gaëtan [Auteur]
Dangers, Laurence [Auteur]
Saccheri, Clement [Auteur]
Prat, Gwénaël [Auteur]
Lacave, Guillaume [Auteur]
Sedillot, Nicholas [Auteur]
Terzi, Nicolas [Auteur]
La Combe, Béatrice [Auteur]
Mira, Jean-Paul [Auteur]
Romen, Antoine [Auteur]
Azais, Marie-Ange [Auteur]
Rouze, Anahita [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Unité de Glycobiologie Structurale et Fonctionnelle - UMR 8576 [UGSF]
Devaquet, Jérôme [Auteur]
Delbove, Agathe [Auteur]
Dres, Martin [Auteur]
Bourenne, Jeremy [Auteur]
Lautrette, Alexandre [Auteur]
de Keizer, Joe [Auteur]
Ragot, Stéphanie [Auteur]
Frat, Jean-Pierre [Auteur]
Gacouin, Arnaud [Auteur]
Coudroy, Rémi [Auteur]
Ehrmann, Stephan [Auteur]
Quenot, Jean-Pierre [Auteur]
Nay, Mai-Anh [Auteur]
Guitton, Christophe [Auteur]
Contou, Damien [Auteur]
Labro, Guylaine [Auteur]
Reignier, Jean [Auteur]
Pradel, Gael [Auteur]
Beduneau, Gaëtan [Auteur]
Dangers, Laurence [Auteur]
Saccheri, Clement [Auteur]
Prat, Gwénaël [Auteur]
Lacave, Guillaume [Auteur]
Sedillot, Nicholas [Auteur]
Terzi, Nicolas [Auteur]
La Combe, Béatrice [Auteur]
Mira, Jean-Paul [Auteur]
Romen, Antoine [Auteur]
Azais, Marie-Ange [Auteur]
Rouze, Anahita [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Unité de Glycobiologie Structurale et Fonctionnelle - UMR 8576 [UGSF]
Devaquet, Jérôme [Auteur]
Delbove, Agathe [Auteur]
Dres, Martin [Auteur]
Bourenne, Jeremy [Auteur]
Lautrette, Alexandre [Auteur]
de Keizer, Joe [Auteur]
Ragot, Stéphanie [Auteur]
Frat, Jean-Pierre [Auteur]
Journal title :
New England Journal of Medicine
Abbreviated title :
N Engl J Med
Volume number :
387
Pages :
1843-1854
Publisher :
Massachusetts Medical Society
Publication date :
2022-11-17
ISSN :
0028-4793
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
BACKGROUND
Spontaneous-breathing trials can be performed with the use of either pressure-
support ventilation (PSV) or a T-piece. Whether PSV trials may result in a shorter
time to tracheal extubation than T-piece trials, ...
Show more >BACKGROUND Spontaneous-breathing trials can be performed with the use of either pressure- support ventilation (PSV) or a T-piece. Whether PSV trials may result in a shorter time to tracheal extubation than T-piece trials, without resulting in a higher risk of reintubation, among patients who have a high risk of extubation failure is un- known. METHODS In this multicenter, open-label trial, we randomly assigned patients who had a high risk of extubation failure (i.e., were >65 years of age or had an underlying chronic cardiac or respiratory disease) to undergo spontaneous-breathing trials performed with the use of either PSV (with a pressure-support level of 8 cm of water and no positive end-expiratory pressure) or a T-piece. The primary outcome was the total time without exposure to invasive ventilation (reported as the number of ventilator-free days) at day 28 after the initial spontaneous-breathing trial. Secondary outcomes included extubation within 24 hours and extubation within 7 days after the initial spontaneous-breathing trial, as well as reintubation within 7 days after extubation. RESULTS A total of 969 patients (484 in the PSV group and 485 in the T-piece group) were included in the analysis. At day 28, the median number of ventilator-free days was 27 (interquartile range, 24 to 27) in the PSV group and 27 (interquartile range, 23 to 27) in the T-piece group (difference, 0 days; 95% confidence interval [CI], −0.5 to 1; P = 0.31). Extubation was performed within 24 hours in 376 patients (77.7%) in the PSV group and in 350 patients (72.2%) in the T-piece group (difference, 5.5 per- centage points; 95% CI, 0.01 to 10.9), and extubation was performed within 7 days in 473 patients (97.7%) and 458 patients (94.4%), respectively (difference, 3.3 per- centage points; 95% CI, 0.8 to 5.9). Reintubation was performed in 72 of 481 pa- tients (14.9%) in the PSV group and in 65 of 477 patients (13.6%) in the T-piece group (difference, 1.3 percentage points; 95% CI, −3.1 to 5.8). Cardiac or respira- tory arrest was a reason for reintubation in 9 patients (3 in the PSV group and 6 in the T-piece group). CONCLUSIONS Among patients who had a high risk of extubation failure, spontaneous-breathing trials performed with PSV did not result in significantly more ventilator-free days at day 28 than spontaneous-breathing trials performed with a T-piece. (Supported by the French Ministry of Health; TIP-EX ClinicalTrials.gov number, NCT04227639.)Show less >
Show more >BACKGROUND Spontaneous-breathing trials can be performed with the use of either pressure- support ventilation (PSV) or a T-piece. Whether PSV trials may result in a shorter time to tracheal extubation than T-piece trials, without resulting in a higher risk of reintubation, among patients who have a high risk of extubation failure is un- known. METHODS In this multicenter, open-label trial, we randomly assigned patients who had a high risk of extubation failure (i.e., were >65 years of age or had an underlying chronic cardiac or respiratory disease) to undergo spontaneous-breathing trials performed with the use of either PSV (with a pressure-support level of 8 cm of water and no positive end-expiratory pressure) or a T-piece. The primary outcome was the total time without exposure to invasive ventilation (reported as the number of ventilator-free days) at day 28 after the initial spontaneous-breathing trial. Secondary outcomes included extubation within 24 hours and extubation within 7 days after the initial spontaneous-breathing trial, as well as reintubation within 7 days after extubation. RESULTS A total of 969 patients (484 in the PSV group and 485 in the T-piece group) were included in the analysis. At day 28, the median number of ventilator-free days was 27 (interquartile range, 24 to 27) in the PSV group and 27 (interquartile range, 23 to 27) in the T-piece group (difference, 0 days; 95% confidence interval [CI], −0.5 to 1; P = 0.31). Extubation was performed within 24 hours in 376 patients (77.7%) in the PSV group and in 350 patients (72.2%) in the T-piece group (difference, 5.5 per- centage points; 95% CI, 0.01 to 10.9), and extubation was performed within 7 days in 473 patients (97.7%) and 458 patients (94.4%), respectively (difference, 3.3 per- centage points; 95% CI, 0.8 to 5.9). Reintubation was performed in 72 of 481 pa- tients (14.9%) in the PSV group and in 65 of 477 patients (13.6%) in the T-piece group (difference, 1.3 percentage points; 95% CI, −3.1 to 5.8). Cardiac or respira- tory arrest was a reason for reintubation in 9 patients (3 in the PSV group and 6 in the T-piece group). CONCLUSIONS Among patients who had a high risk of extubation failure, spontaneous-breathing trials performed with PSV did not result in significantly more ventilator-free days at day 28 than spontaneous-breathing trials performed with a T-piece. (Supported by the French Ministry of Health; TIP-EX ClinicalTrials.gov number, NCT04227639.)Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
CNRS
CNRS
Research team(s) :
Glycobiology in fungal Pathogenesis and Clinical Applications
Submission date :
2024-02-27T14:26:43Z
2024-03-01T09:59:18Z
2024-03-01T09:59:18Z
Files
- P22.61 nejmoa2209041.pdf
- Version éditeur
- Restricted access
- Access the document